Security National Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$4.16M Hold
62,320
0.96% 36
2021
Q2
$4.16M Sell
62,320
-1,075
-2% -$70.1K 0.93% 37
2021
Q1
$4M Sell
63,395
-1,283
-2% -$79.8K 0.94% 33
2020
Q4
$4.01M Buy
64,678
+2,153
+3% +$132K 1% 31
2020
Q3
$3.77M Buy
62,525
+450
+0.7% +$27.1K 1.06% 28
2020
Q2
$3.65M Sell
62,075
-870
-1% -$52K 1.09% 27
2020
Q1
$3.51M Sell
62,945
-422
-0.7% -$25.8K 1.28% 22
2019
Q4
$4.07M Buy
63,367
+2,199
+4% +$126K 1.18% 28
2019
Q3
$3.1M Sell
61,168
-1,850
-3% -$86.9K 0.97% 36
2019
Q2
$2.86M Sell
63,018
-235
-0.4% -$10.9K 0.9% 38
2019
Q1
$3.02M Buy
63,253
+3,247
+5% +$162K 0.97% 35
2018
Q4
$3.12M Buy
60,006
+925
+2% +$49.7K 1.16% 26
2018
Q3
$3.67M Sell
59,081
-635
-1% -$37.7K 1.15% 28
2018
Q2
$3.3M Sell
59,716
-1,925
-3% -$104K 1.1% 27
2018
Q1
$3.9M Sell
61,641
-6,100
-9% -$392K 1.3% 22
2017
Q4
$4.15M Sell
67,741
-2,910
-4% -$182K 1.34% 17
2017
Q3
$4.5M Sell
70,651
-1,164
-2% -$68K 1.48% 13
2017
Q2
$4M Sell
71,815
-660
-0.9% -$35.9K 1.34% 20
2017
Q1
$3.94M Buy
72,475
+277
+0.4% +$15.2K 1.33% 19
2016
Q4
$4.22M Sell
72,198
-782
-1% -$42.8K 1.51% 18
2016
Q3
$3.94M Buy
72,980
+164
+0.2% +$10.5K 1.43% 19
2016
Q2
$5.36M Sell
72,816
-1,191
-2% -$84.2K 1.97% 7
2016
Q1
$4.73M Sell
74,007
-590
-0.8% -$37.2K 1.78% 10
2015
Q4
$5.13M Sell
74,597
-554
-0.7% -$36.6K 2.01% 5
2015
Q3
$4.45M Buy
75,151
+205
+0.3% +$13K 1.73% 11
2015
Q2
$4.99M Buy
74,946
+300
+0.4% +$19.8K 1.79% 9
2015
Q1
$4.82M Sell
74,646
-2,400
-3% -$150K 1.71% 10
2014
Q4
$4.55M Buy
77,046
+19,339
+34% +$1.09M 1.66% 10
2014
Q3
$2.95M Sell
57,707
-19,636
-25% -$981K 1.2% 30
2014
Q2
$3.75M Sell
77,343
-1,830
-2% -$90.2K 1.46% 18
2014
Q1
$4.11M Sell
79,173
-3,010
-4% -$160K 1.67% 12
2013
Q4
$4.37M Sell
82,183
-1,985
-2% -$101K 1.81% 11
2013
Q3
$3.89M Sell
84,168
-1,648
-2% -$72.3K 1.75% 10
2013
Q2
$3.83M Buy
+85,816
New +$3.73M 1.85% 11

Other funds holding BMY

Security National Trust's BMY Position: Q3 2021 in Review

Security National Trust held its Bristol-Myers Squibb (BMY) position steady in Q3 2021 at 62,320 shares worth $4.16M. The position accounts for 0.96% of the portfolio, ranked #36.

Security National Trust first reported a position in BMY in Q2 2013 and has held it in 34 quarters since. The position peaked at $5.36M in Q2 2016. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Security National Trust held 62,320 shares of Bristol-Myers Squibb worth $4.16M as of Q3 2021.
  • Security National Trust left its Bristol-Myers Squibb share count unchanged in Q3 2021.
  • Bristol-Myers Squibb made up 0.96% of Security National Trust's portfolio in Q3 2021, its #36 holding.
  • Security National Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 34 quarters since.
  • Security National Trust's Bristol-Myers Squibb position peaked at $5.36M in Q2 2016.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.